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ABSTRACT
The antipsychotic drug “haloperidol” (HAL) has been widely used for the treatment of a range of neuropsychiatric disorders. However
treatment also induces extrapyramidal symptoms (EPS) including short term parkinsonism and late complication tardive dyskinesia (TD).
These idiopathic symptoms are associated with serious limitations in this therapy. Some studies have suggested that oxidative stress induced
during the metabolism of HAL is involved in the elicitation of EPS. We speculated if green tea may prevent HAL-induced EPS because
of its antioxidant properties. In the present study, the efficacy of green tea extract (GTE) given as a sole source of water on HAL-induced
EPS male albino wistar rats was examined. We found that HAL-induced motor deficits and elicitation of TD were more severe in GTE
than water dinking animals. HAL-induced dopamine level was increased and its metabolites concentrations were higher in the nucleus
accumbens and lower (p < 0.01) in the caudate of GTE-drinking than water-drinking animals. Increased ratios of homovanillic acid (HVA)
and 3, 4-dihydroxyphenylacetic acid (DOPAC)/dopamine in the caudate may be involved in the precipitation of HAL-elicited EPS while
drinking GTE. Conversely GTE increased the level of dopamine moreover raised its metabolites in the nucleus accumbens may relapsed
the schizophrenic symptoms while on the treatment HAL. We thus suggest that patients on HAL therapy should avoid green tea.
Key words: Green Tea, Camellia sinensis, Haloperidol, Nucleus Accumbens, Caudate Putamen, Extrapyramidal Symptoms,
Parkinsonism, Tardive Dyskinesia, Tardive Myoclonus

INTRODUCTION
Haloperidol treatment has been shown to produce oxidative stress in patients with acute neuropsychiatric symptoms.
Oxidative stress has also been implicated with the HALinduced extrapyramidal symptoms (EPS)(1-3).
EPS is characterized with initial parkinsonian-like
symptoms, and late complications are dyskinesia syndromes.
Studies on animal models showed that acute administration
of HAL elicits motor deficits homologous to parkinsonianlike symptoms of humans. Impairment in motor coordination
can be quantified in rats using rota rod(5-10). On the other hand
rats treated with repeated chronic doses of HAL develop late
complication i.e. orofacial movements described as tardive
syndromes, such as tardive vacuous chewing movement
(tVCMs)(9) and tardive myoclonus(11). tVCMs are used for
tardive dyskinesia (TD) quantification in rat model(9).
* Author for correspondence. Tel: +92-334-204-3442;
Fax: +92-213-5377846; Email: Tafheemm85@gmail.com

HAL is known to have high affinity for dopamine D2
type receptors. By blocking D2 type receptors in the corpus
striatum it treated psychiatric symptoms besides elicited
syndromes(9,10,12). Hence HAL with its metabolites provides
both therapeutic action and adverse events through striatal
neurons(3) which are often suggested to eradicate symptoms
of idiopathic EPS with the placement of antioxidative effects
on neurons. It could reduce the symptoms that appear in the
course and development of EPS(11,13-14).
The neuropathology associated with EPS within and
around the region is thought to involve excessive production of free radicals and dopamine autoxidation. The detail
mechanistic studies have shown that dopamine and serotonin
interact antagonistically in the caudate to control motor
activity(6). Nucleus accumbens is a region of brain known
to be involved in emotional control. Both striatal regions are
affected by dopamine autoxidation during HAL therapy(15).
The ratios of dopamine metabolites to dopamine are known
indicators that depict the clear picture of the HAL-induced
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adverse events. Report from our laboratory provided evidence
that the increase in dopamine metabolism is directly proportional to the increase in EPS events(6).
Some reports have suggested that the constituents of
green tea have antioxidative properties that may have protective effects against chemotoxicants to reduce distressing
effects(16-18). Conversely our recent report(19) and other
studies together have found its properties controversial.
Therefore the current study concerns with the effects of
green tea extract (GTE) on HAL-induced EPS in rats. In order
to understand the role of dopamine and its metabolites in the
modulation of HAL-induced EPS, we determined homovanillic acid (HVA) and 3, 4-dihydroxyphenylacetic acid
(DOPAC) concentrations and ratios to dopamine concentration in the caudate and nucleus accumbens of the rat brain.

MATERIAL AND METHODS
Male albino Wistar rats (150g-200g) were housed individually under standard laboratory conditions maintained on
a 12-hour light/dark cycle with free access to food, rodent
diet pellets and water was allowed libidum for the first week.
Animals were acclimatized to laboratory conditions before
the experiment.
I. Treatment
Twenty four animals were randomly divided into four
groups (six animals in each group): (I) water plus saline (Π)
water plus HAL (Ш) GTE plus saline (IV) GTE plus HAL.
The green tea 1 g was extracted with hot (boiling) water (1
L) for 5 minutes. It was freshly made in 24 h and provided as
a sole source of water. HAL (Serenace; Searl) was injected
1 mg/Kg daily and equal volume of saline 1 mL/Kg daily was
injected to the controls intraperitonealy (IP). The doses were
administered according to a balanced design between 10:00
and 12:00 h.
II. Behavioral Experiments
All behavioral experiments were conducted at room
temperature in noise-protected environment. Behavioral
assessments were repeated every 6th day of the week.
III. Motor Function Tests
(I) Monitoring Motor Coordination
Motor coordination was monitored on a Rota-Rod®
System (UGO BASILE, Biological research apparatus,
COMERIO, Varese, Italy). The Rota-Rod with a drum of
7 cm diameter was adjusted on 2-20 revolution per l min (rpm)
speed. Rats were trained to maintain balance on a rotating bar,
until they attained 150 s walking on rotating bar. The latency
to fall in test session of 150 s was taken as a measure of motor
coordination monitored after 1 hour of HAL administration.

(II) Quantification of Tardive Syndromes, Orofacial Dyskinesia and Myoclonus
Two movement disorders units were used to establish
drugs responsible for tardive syndromes or ‘TS’ (tardive
orofacial dyskinesia, and myoclonus). tVCMs is an analogous
model of orofacial dyskinesia, characterized by purposeless
spontaneous opening of mouth with or without tongue protrusion(20). According to the revised model for orofacial dyskinesia in rats, tVCM were described(22). We reduced methodological discrepancies and used young rats in order to avoid
age related movement deficits in this experiment. We also
increased cage size that helps to maintain stressless condition
as tVCMs are known to be sensitive to stress. The lowered
incidence of dyskinesia during stress is well documented. The
incidence of tVCMs was monitored both live and with video
recording after the 3rd week of i.p. administration of HAL in
both GTE and water-drinking animal groups.
Animals were placed individually in a rectangular
prespex activity cage (26/26/26 cm) with a sawdust-covered
floor and observed for a period of 15-min. Orofacial dyskinesia was quantified during 10-min observation period.
Each chewing episode was scored as a “1”. A chewing
period consists of distinct bursts of three to five masticatory movements and lasts for 2-5 s. Masticatory movements
were referred as single mouth openings in the vertical plane
not directed toward physical material. Recently Lerner
& colleague described “tardive myoclonus”, movement
disorder as brief jerks of muscles in legs, neck, trunk, and
extremities(11). A rat model of tardive myoclonus was defined
as jerky movements in legs and extremities. We observed and
counted appearance of tardive myoclonus in separate mode
of motor deficits. The individual rat was constantly observed
by an observer blind to the treatment. The tardive myoclonus
and tVCMs were monitored at the cut-off time of 10 min that
began 4 h after HAL administration.
IV. Dissection of Striatum
The animals were killed 20 h after the last injection of
HAL on the 43rd day to collect brain samples for the neurochemical analysis.
The dissection procedure of the brain was essentially
the same as described before(6,19). A fresh brain was dipped
in ice-cold saline and placed with its ventral site up in the
molded cavity of a brain slicer (Alto matrices). Fine fishing
line wire was inserted into the slots of the slicer to give slices
of 2 mm thickness. The slice containing striatum was transferred to a slide kept on iced normal saline. Punches of 2.5
mm diameter were made bilaterally in the striatum to collect
the brain regions in both dorsal and ventral regions of the
striatum. The regions were isolated and identified according
to the rat brain atlas(23).
Samples were obtained and stored at -70°C for neurochemical analysis of dopamine and its metabolites on the 57th
day of treatment.
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I. Brain Regional Analysis by HPLC- EC Technique
A shim-pack XR-ODS Shimadzu separation column
of (5 µ pore size; 4.5 mm I. D. × 15 cm) was used. The
mobile phase was 0.1 M sodium phosphate buffer (pH 2.9)
containing 14% methanol (HPLC grade), 0.023% OSS, and
0.005% EDTA. Electrochemical detection was done at an
operating potential of 0.8 V (glassy carbon electrode vs. Ag/
AgCl reference electrode).
II. Statistical Analysis
Data are presented as means ± SD. With SPSS 11.5 software, data on rota rod and treatment induced weekly changes
were recorded in the motor coordination tVCMs were
analyzed by two-way ANOVA (repeated measure design). By
using two-way ANOVA for behavior tardive myoclonus, and
neurochemical parameters analysis individual comparison
was made by Bonferroni test. Probability and ratios were
considered significant at values less than 0.05.

RESULTS
The control rats consumed an average of 31 ± 1 mL
water/day, while rats on GTE groups consumed 35 ± 6 mL on
day 1, then reached maximum intake of 41 ± 3 mL on day 42.
The HAL-treated group consumed 19 ± 2 mL water per day
and HAL treated GTE drinking group of animals consumed
21 ± 4 mL/day.
The three-way ANOVA of rota rod performance showed
significant effects of HAL (F = 42.41 df = 2, 23, p < 0.01)
and GTE (F = 18.85 df = 2, 23, p < 0.01) while weekly effects
(F = 56.14 df = 2, 23, p < 0.01) were also significant (Figure 1).
Rota rod performance was decreased in both HAL-treated
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groups of animals. HAL-induced decreased performance on
rota rod was smaller in water drinking than in GTE drinking
animals. Rota rod performance was steady after 3rd weeks of
water-drinking HAL-treated animals. However, water intake
decreased greatly in GTE plus HAL treated group of animals
in this duration.
HAL injection started to elicit tVCMs (df 1,20) after
3-weeks of administration in both GTE and water drinking
animals (F = 54, df 4, 40, p < 0.01) while tVCMs did not
appear in animals drinking GTE or water in the absence of
HAL administration. HAL-induced tVCMs was progressively greater (p < 0.01) in the GTE drinking animals in
comparison with water drinking group (F = 46.7 df = 4, 40,
p < 0.01) (Figure 2). Weekly effect (F = 34.4 df = 4, 40,
p < 0.01) was also significant between groups of animals.
HAL injection also elicited tardive myoclonus (Figure 3)
parallel to tVCMs (df 1, 20) after 3-week of administration in
both GTE (F = 18.7, p < 0.01) and water (F = 11.5, p < 0.01)
drinking animals while tardive myoclonus did not appear
in GTE and water drinking animals in the absence of HAL.
Interaction of GTE on HAL treatment was also significant
(F = 15.3, p < 0.01). HAL-induced tardive myoclonus complication was significantly enhanced (p < 0.01) in GTE-drinking
animals in comparison with water drinking group (Figure 3).
The alteration in dopamine and its metabolites concentrations in caudate region (Figure 4) became (df 1,20) significant after 6-weeks of HAL administration (F = 5.3, p < 0.01)
and GTE drinking (F = 8.0, p < 0.01), while interaction of
GTE was also significant (F = 6.3, p < 0.01) on dopamine
concentration in the caudate region of animals. Post hoc
analysis showed that dopamine concentration decreased
significantly (p < 0.01) in HAL plus GTE group of animals.
Dopamine concentration was lower in GTE-drinking than
water-drinking control animals. HAL-induced dopamine
concentration was more decreased in GTE than in water
drinking animals.
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Figure 1. HAL effects on oral administration of water / GTE fluid
taking group of animals monitored on rota rod performance. Values are
means ± SD (n = 6). *p < 0.01 from respective saline treated group, + p
< 0.01 from respective water treated group following two-way ANOVA
repeated measure design.
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Figure 2. HAL effects on water / GTE fluid drinking group of animals
monitored (4th-6th weeks) for HAL-induced tVCMs count. tVCMs
appeared after 3rd week of repeated HAL administration. Values are
means ± S.D. (n = 6). *p < 0.01 from respective weekly differences
among groups + p < 0.01 from respective water treated group following
two-way ANOVA repeated measure design.
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GTE drinking than water drinking controls animals. Either
GTE drinking or HAL treated plus water drinking animals
showed increased DOPAC concentration in the caudate
region. However the increased DOPAC concentration elicited
by either HAL or GTE alone was decreased or not altered in
GTE plus HAL treated animals.
HAL injection elicited alteration of HVA concentration
in caudate region after 6 weeks of administration in both
water and GTE drinking animals (Figure 4) where it showed
(df 1,20) significant effects of GTE (F = 6.9, p < 0.01) HAL
(F = 5.3, p < 0.01). Interaction between GTE and HAL was
also significant (F = 1.9, p < 0.05) on the HVA concentration in caudate region. Post hoc analysis showed that the
HVA concentration was significantly (p < 0.01) decreased
in the caudate region of HAL injected GTE drinking group
of animals. HVA concentration was greater in GTE drinking
than in water drinking control animals. The increase in HVA
concentration by GTE alone was less than that in HAL treated
water drinking animals. The increased HVA concentration induced by HAL was significantly diminished in GTE
drinking HAL administered group of animals.
HAL injection elicited the alteration in dopamine and its
metabolites after 6 weeks in the nucleus accumbens in water
and GTE drinking animals (df 1, 20) which showed (Figure 5)
significant effects of GTE (F = 5.7, p < 0.01) HAL (F = 7.3,
p < 0.01). Interaction of GTE and HAL treatment was also
significant (F = 6.63, p < 0.01) on dopamine concentration
in the nucleus accumbens. Post hoc analysis showed that
the concentration of dopamine was significantly increased

HAL injection elicited the alteration of DOPAC concentration in caudate region of both water and GTE drinking
animals (Figure 4), which showed (df 1,20) significant effects
after 6 weeks of HAL administration (F = 14.6, p < 0.05) and
GTE drinking (F = 18.3, p < 0.01). The interaction between
GTE and HAL was also significant (F = 6.8, p < 0.05) on
DOPAC concentration in caudate region of animals. Post
hoc analysis showed that DOPAC concentration was significantly decreased (p < 0.01) in caudate region of HAL plus
GTE treated animals. DOPAC concentration was greater in
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Figure 3. Effects of repeated injection of HAL on tardive myoclonus
counts in the group of animals drinking GTE/water fluids. Tardive
myoclonus appeared after 3rd week of repeated HAL administration.
Values are means ± SD (n = 6). significant difference * p < 0.01 from
respective controls + p < 0.01 from respective water treated group
following two-way ANOVA repeated measure design.
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Figure 4. Effects of oral administration of GTE/water intake on dopamine and its metabolites (DOPAC and HVA) concentration in the caudate of
HAL-treated group of animals. Values are means ± SD. After 20 h of the last administration of the HAL, + p < 0.01 from respective saline injected
rats from **p < 0.05 *p < 0.01 the respective water treated rats following two-way ANOVA.
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(p < 0.01) in the nucleus accumbens of HAL injected GTE
drinking group of animals while dopamine concentration
was greater in GTE drinking than in water drinking control
groups. Both groups of animals drinking GTE showed
increase in dopamine concentration in the nucleus accumbens. Dopamine concentration was decreased in HAL treated
water drinking animals. HAL-induced decreased dopamine
concentration was reversed in GTE drinking HAL treated
group of animals.
HAL injection elicited the alteration in DOPAC concentration which was observed after 6 weeks of treatment in the
nucleus accumbens of both water and GTE drinking animals
(df 1,20) as shown in Figure 5 with the effects of GTE
(F = 3.2, p > 0.05) and HAL (F = 9.4, p > 0.05). Interaction
between GTE and HAL was significant (F = 6.8, p < 0.05)
on DOPAC concentration in the nucleus accumbens. Post
hoc analysis showed that DOPAC concentration was
significantly (p < 0.01) increased in the HAL-injected GTE
drinking animals where DOPAC concentration not altered by
HAL in water drinking animals. DOPAC concentration was
not altered in GTE drinking control animals. Combination of
HAL with GTE elicited much increase of DOPAC concentration in the nucleus accumbens of treated animals.
HAL injection also elicited the alteration of HVA
concentration, which was observed after 6-weeks in the
nucleus accumbens of both water and GTE-drinking animals
(df 1,20), as shown in Figure 5 with significant effects of GTE
(F = 6. 9, p < 0.01) and HAL (F = 5.3, p < 0.01). Interaction
of GTE with HAL injection was also significant (F = 4.9,
p < 0.05) on the change of HVA concentration in nucleus
accumbens. Post hoc analysis showed HVA concentration in

the nucleus accumbens was remarkably increased (p < 0.01)
in HAL injected GTE drinking animals. HVA concentration
was increased by HAL treatment in water drinking groups
while HVA did not change in the absence of HAL either
in GTE or water-drinking group of animals. HAL-induced
elevation of HVA concentration was even greater in GTE
drinking group.
HAL-induced DOPAC/dopamine turnover ratio was
2-3 folds greater (p < 0.01) in GTE drinking (-82%) than
water drinking animals in the caudate region (Table 1). In
the absence of HAL, DOPAC/dopamine turnover ratios of
GTE drinking group were not significantly (p > 0.5) altered
to the control group animals, whereas in the HAL injected
groups this ratio was significantly increased. HAL-induced
HVA/dopamine turnover ratio was 3 folds greater (p < 0.01)
in the GTE drinking (-62%) than water drinking animals.
In the absence of HAL, HVA/dopamine turnover ratios of
GTE drinking group were not significantly (p > 0.5) altered
to the control group of saline treated animals, whereas in
HAL injected group this ratio was significantly (p < 0.01)
increased (-102%) compared to the control group.
In nucleus accumbens, the DOPAC/dopamine turnover
ratio was significantly (p < 0.01) increased (-88%) in HALinjected GTE drinking than HAL treated water drinking
animal group (Table 1). DOPAC/dopamine turnover ratios
were greater (-53%) in GTE drinking as compared to HAL
injected GTE drinking group, where these ratios were 8%
greater (p > 0.5) in controls. HVA/dopamine turnover was
(p < 0.01) significantly (4 folds) greater in HAL-injected
GTE drinking group than water drinking HAL injected
animals. An increase of HAL-induced HVA/dopamine

Dopamine

Conc ( ng / g)

700

+

600
500

*+

+

Saline
HAL

400

+

300
200
100
0

Water

TEG

HVA
200

*+
Conc( ng / g)

Conc ( ng / g )

DOPAC
1600
1400
1200
1000
800
600
400
200
0

+

100

GTE

*

+

50
0

Water

*+

150

Water

GTE

Figure 5. Effects of oral administration of GT intake on dopamine and its metabolites (DOPAC and HVA) concentration in the nucleus accumbens
of HAL-treated group of animals. Values are means ± SD. After the 20 h of last administration of the HAL significant differences from + p < 0.01
respective saline injected rats from *p < 0.01 respective water treated rats following two-way ANOVA.
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DOPAC /
Dopamine

Table 1. Dopamine turnover ratios in caudate and nucleus accumbens regions of rat brain
Caudate (n = 6)
Control
Water

HVA /
Dopamine

HAL
GTE

1.8 ± 0.3

2.1 ± 1.1

Water

0.07 ± 0.0

Control
GTE
+

2.8* ± 0.5

Control
Water

Nucleus Accumbens (n = 6)

3.4* ± 0.0

Water

GTE

Water

GTE

1.5 ± 0.7

1.3 ± 0.04

2.4* ± 0.0

2.8*+ ± 0.0

HAL
GTE

0.16 ± 0.0

HAL

Control

HAL

Water

GTE

Water

GTE

Water

GTE

0.34* ± 0.0

+

1.2 ± 0.7

1.4 ± 0.0

1.8* ± 0.01

2.7*+ ± 0.0

0.37* ± 0.0

Shown means ± SD in ng/mg net weight and means of ratios.
*p < 0.01 from respective saline injected controls.
+p < 0.01 from respective water drinking.

turnover in the nucleus accumbens region became even more
increased in GTE drinking HAL injected animals, which was
distinctly different from water drinking controls. In GTE
drinking group, the HVA/dopamine turnover ratio was (p <
0.05) significantly smaller than the other GTE group of HAL
injected animals. However the HVA/dopamine turnover
ratios of GTE drinking group were not significantly different
to controls.

DISCUSSION
Fluid intake was reduced in both HAL-treated GTE/
water drinking groups of animals; however, it was interesting
to observe that GTE intake was greater than water intake in
HAL treated animals. It has been reported that the low doses
of HAL lead to lower water consumption(24).
Data in this study showed that HAL-injected animals
drinking either GTE or water for six weeks exhibited significant EPS. As it has been demonstrated in our pilot study that
oral administration of HAL also impaired motor coordination significantly, whose extent was more in rats drinking
GTE as compared to water-drinking ones(19). Our present
data suggested for the first time the effects on metabolism in
the animals drinking GTE and treated with HAL at the same
time. Increased HAL-induced parkinsonian-like locomotor
deficit was observed in parallel in both HAL treated groups.
However, marked difference in both HAL treated groups was
also observed on the 5th to 6th weeks. A report has suggested
that the HAL treatment produces tolerance in motor deficits
on the 3rd week following HAL treatment(9); conversely
there was no tolerance observed in HAL treated GTE
drinking animals in this study. HAL treated water drinking
group showed tolerance at the 3rd week in comparison and
some levels of drug tolerance also appeared in this group of
animals. Hence it was contradictory to our hypothesis that
GTE may reduce the HAL-elicited movement deficits.
Results in Figure 2 demonstrated significant difference
in motor coordination during 4th to 6th weeks of HAL injection in animal group drinking water and GTE. A report where
the mice model of Parkinson’s diseases (PD) was employed
showed that the GTE alone has no significant effect on PD.

However it was interesting to note that 5 mg/Kg GTE caused
an elevation in dopamine metabolism that was significantly
amplified at MPTP (N-ethyl-4 Phenyl-1, 2, 3, 6-tetrahydropyradine) effects of PD elicitation(25).
In current study design, GTE potentiated the HALinduced parkinsonian like symptoms that was monitored on
rota rod. Martins et al,(26) have reported neuroleptic elicited
high altitude of dopaminergic metabolism produce reactive
oxygen species (ROS) and subsequent neuroleptic-induced
neurodegeneration. Here it may be possible that HAL bound
the free radical of scavenging GTE properties and had potential to make GTE a pro-oxidative agent. A report has demonstrated that the green tea acts as a pro-oxidative agent itself
and significantly increases hydrogen peroxide (H2O2) levels
in a dose dependent manner(27). Linking from that study, we
can postulate that HAL might have potential to alter the antioxidative properties of GTE and exert its effects in a manner
of converting into potential pro-oxidant-like effects that
could result in the increase of metabolism in animals showing
severe EPS.
This study also validated Haleem’s report that tVCMs
are a late-appearing complication of HAL which precipitating
in doses-dependent manners overtime(9); these effects were
definite in both HAL treated groups shown in the current
study. Data demonstrated that high rate of early and late
complications in the movement syndromes appeared at both
acute and chronic treatment of HAL. HAL-induced precipitation in tVCMs appeared in timely manners in GTE drinking
HAL treated animals. tVCMs symptoms were greater in
GTE drinking than in water drinking HAL treated group of
animals. It is well documented(9) that the increased precipitation of late-appearing tVCMs complication simultaneously
appears with myoclonus symptoms on the 3rd week of HAL
treatment, which is also evidently shown in this study.
High differential rates of deficits were recorded in later
weeks of HAL treatment in GTE and than in water drinking
animals. It has been documented HAL-induced apoptosis
upon oxidative stress produced by antagonizing dopaminergic receptors in the striatum would elicit tVCMs symptoms,(28) and we here postulated that green tea may enhance
HAL-induced mechanism that depicted higher movement
symptoms. To our knowledge this is first time the database
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of myoclonus movement disorder unit was reported drug
responsible extrapyramidal symptoms. Both tardive dyskinesia and myoclonus are clinically presented differently
in patients over the HAL therapy. Suenaga et al.(28) have
described HAL responsible tardive types that were clinically
presented in patients with persistent EPS such as dyskinesia,
choreatic movement and myoclonus. We observed and
counted the appearance of tardive myoclonus as a separate
mode of movement deficits in rats (presented in Figure 4).
Reporting myoclonus type-symptoms in rat model of EPS,
HAL-induced jerky movements of extremities was monitored
mainly in legs. HAL-elicited EPS were more found sever in
GTE-drinking animals as compared with water drinking ones.
Our study is the first presenting data on the striatal
behavior as well as dopamine turnover rates with a
pronounced alteration via GTE drinking in the rodent’s brain
regions. Studies have clearly shown a direct relationship
between dopaminergic metabolism and elicitation of EPS
in rodents(6,19). The ratio of striatal HVA/DA, as a measure
of the synaptic dopamine turnover was already observed
increased in patients with mild symptoms of movement
deficits(29). HAL-treated animals with increased motor deficits and have also shown motor-related events in the striatal
region. Anatomical site of HAL action in the striatum is well
documented, that has demonstrated regional involvements
in uncontrolled motor-nerves. Clinically effective doses of
HAL occupy 60-80% of brain dopamine D2 type receptors,
as measured by Positron Emission Tomography (PET) in the
human striatum(30,31). Occupancy at striatal dopaminergic
receptors caused motor deficits at HAL-elicited threshold
acute side effects parkinsonism and chronic thresholdinduced tardive symptoms. Striatum receives input from
dopaminergic neurons(32). Supersensitive responsiveness of
the post synaptic D2 type receptors contributed to the emergence of these syndromes(7).
Interestingly, an increased of dopamine level and its
metabolites causes Schizophrenia(33-35). Results from GTE +
HAL group have shown that increased levels of dopamine
and its metabolites in the nuclease accumbens may cause
relapse of Schizophrenia.
Evidence has supported that the status of this regional
dopaminergic metabolism may possibly antagonize HAL
effects and also may lead to the relapse of the schizophrenic
symptoms(11,33-35). HAL is not effective in negative symptoms of schizophrenia(33). The negative symptom complex
of schizophrenia has been associated with low dopamine
and high metabolites levels. Also it has been reported that
increase in dopamine metabolism was found in post-mortem
patient of schizophrenia. Low level of dopamine and high
level of metabolites in schizophrenic patients were found
in caudate(34) which are more likely to lead to a relapse of
hallucination due to drinking GTE with the HAL treatment.
Therefore, it enhances the possibility that GTE may exaggerate negative deficits complex plus hallucination relapse in
schizophrenic patients. Motor impairment can be correlated
with dopamine, DOPAC and HVA concentrations in caudate.
DOPAC is often considered as an index of intraneuronal

dopaminergic catabolism(35). Studies have recommended that
acute administration of HAL increases DOPAC(36) and HVA
levels(37). It can be suggested that dopamine availability to
dopamine metabolism ratio augmented motor impairment.
In dose-dependent manners these symptoms last at greater
magnitude and longer duration in the brain striatum(38). This
study consolidated previous results to understand GTE and
HAL effects on dopamine metabolism. Here it was very
interesting to note that solely GTE effects on dopamine and
its metabolism on rodent brains that mimicked to the human
brain(19).
The long term administration of HAL is involved in
an increase of sensitivity of the D2 receptors. Dopamine D2
receptors are intensely positioned both presynaptically and
postsynaptically in striatal dopaminergic neurons(7,37). It is
likely that GTE has presynaptical and postsynaptical roles
in processing and incorporating incoming inputs in nucleus
accumbens but blocks the networking in caudate of the basal
ganglion. We speculate that the delay of incoming inputs of
D2 receptors from the nucleus accumbens toward the caudate
could be the cause of increased intensity of EPS. It will be
interesting to investigate the role of GTE in pre-and postsynaptical signaling events during integrating and processing
networking between regions.
The present study showed that both HAL and GTE
decreased dopamine level in the caudate region of striatum.
An increase in metabolism of dopamine was in the caudate
region of the striatum may be involved in the potentiations
of EPS. HAL increases and HAL + GTE inversely decreases
dopamine levels in caudate region. It was interesting to note
that the GTE itself increases the dopamine levels in the nucleus
accumbens but did not produce any motor deficits probably
due to normal metabolism of the dopamine in the region. The
different effects of HAL and GTE on motor functions and
dopamine are largely explainable in terms of their activities
at dopamine receptors. Our results suggested that an increase
in the dopamine levels to their metabolite ratio, particularly
in the striatum, may be taken as an increased neurochemical
indexed activity. The ratios of dopamine turnover to the HVA
are known indicators that depict the clear picture of the HALinduced adverse events. As found previously(19) dopamine
metabolism in the dorsal striatum was greatly decreased by
GTE, supporting that decreases in dopamine metabolism
is directly proportional to the precipitation of EPS events
which was also conformed in this study.
Our results (Figure 4 and 5) showed the effect of HAL
on DOAPC levels, which tended to induce large fraction of
dopamine catabolism intraneuronally in the nucleus accumbens. On the other hand an increase level of HVA was also
observed in nucleus accumbens but not in the caudate at
the repeated dose HAL in GTE-drinking animals. It is well
documented that small dose of HAL increases the dopamine
release in striatal regions(39). That is explicable in terms of
increased dopamine release and obstructs respectively in
these brain regions.
The effects on nucleus accumbens are also known to be
involved in the emotional control besides movement control.
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Our unpublished data showed HAL produce effects on the
nucleus accumbens connected to the mood related influence
and GTE had influence on mood events(40) indicating that
GTE along HAL enhances the dopamine and its metabolites
levels in the nucleus accumbens that may have some impact
on mood responsiveness essentially. It could be hypothesized
that the GTE alone and along with HAL may produce some
effects on mood receptivity to some extent; however, the
behavioral assessment is necessary in order to see the effect
on mood impression was not performed in this study.
Authors generally agreed that the clinical response of
neuroleptic is associated with an increase in HVA concentration with adverse events of the HAL therapy(41-43). The
proposed mechanism of HVA changes involves a strong
blockade of pre- and post-synaptic D2 receptors. This blockade
increases the amount of dopamine release on subsequent action
potentials and leads to attenuated dopamine transmission at
the post-synaptic D2 receptors. As biochemical investigations
showed that tolerance developed to the increase of striatal
HVA after chronic treatment of HAL(41) GTE failed to affect
the HVA (Figure 5) content effects. No tolerance developed
to the increase to these events while persistence in latency
to fall from rota rod increased (Figure 1), count of tVCMs
increased (Figure 2) and myoclonus event increased (Figure
3). From these results, it is confirmed that the elevated HVA
concentrations was caused by both HAL and GTE treated
nucleus accumbens (Figure 5) whereas HVA/dopamine
turnover ratio was found significantly (3-4 folds) greater in
GTE drinking HAL treated compared to water drinking HAL
treated animals. As shown from previous studies of HAL,
schizophrenic symptoms appeared at increased dopamine
concentration that potentially precipitated as dopamine turnover occurs over HAL administration(44) with the concomitant increases of dopamine release and later turnover in the
caudate(44,45). However, GTE along HAL administration
significantly decreased the HAL-induced deceases of dopamine concentration and concomitant increases of dopamine
metabolites by means of turnover in the caudate region.
HAL-induced increase dopamine was reversed along with its
metabolites HVA and DOPAC(46), indicating the antagonism
of HAL effects. Here we predict that the antischizophrenic
effects of HAL were antagonized by the GTE administration. In the present study, results suggested that the GTE
along with the HAL administration produces even worse
effect on movements and the possibility of the relapse of
the schizophrenic symptoms while antagonizing the HAL
effects; however this study lacked the behavioral monitoring
of schizophrenic relapse.
A rodent study showed that GTE exerts its paralytic
effects on skeletomotor function that suggested denervated
diaphragm in rodents in a concentration dependent manner(47).
It is evident from our study that GTE interaction with less
concentration of HAL produced greater HAL-induced motor
deficits in animals resulting none of facilitatory motor function in rats.
Despite phytotherapeutic reputation of green tea, some
studies have shown the controversial results(47-52). Major

components of GTE potentiate cytotoxicity-induced by
benzyl-isothiocyanate and H2O2 in human Jurkat T lymphocytes(48). The hydroalcoholic extract of green tea used as
a weight reducing agent, it produces significant hepatotoxicity causing fulminant hepatitis in human who may need
liver transplantation(49,50). It has been reported that GTE
increased the onset and duration of convulsion thus causing
mortality in rodent(51). These studies focused on the adverse
effects and characterized green tea as a health hazardous
beverage. GTE was also associated with neurological events
like seizures(51) confusion and insomnia(52) proven by
clinical trials. Effects on neuromuscular junction-induced
fatigue(51) as well as paralytic effects observed in modifying skeletomotor junction affected motor nerve terminals
and inhibited acetylcholine release which were observed
at frequent intake of green tea(47). Nevertheless it is quite
often used as social drink to enhance performance and
mood states(51). This study does not specify any green tea
component but the whole intake of GTE may interact with
HAL and trigger neurochemical events on central dopaminergic system. Conversely, it will be interesting to define
the component interaction with HAL. Aforementioned
report(19) and current study measured the adverse events
of GTE that are certainly shown a level of importance for
precautionary setup during HAL therapy.

CONCLUSIONS
This study showed that intra-peritoneal injection of
HAL and oral consumption of GTE potentiated acute parkinsonian-like effects that increased over time. The evidence
of central nervous system nucleus accumbens and caudate
may be important to the unique therapeutic effect of this
typical antipsychotic drug in the treatment of symptoms,
especially the deficit symptoms of schizophrenia. GTE has
positive impact at the alteration of dopamine metabolites
and its turnover ratios by antagonizing HAL action in the
nucleus accumbens that potentiate HAL-induce tVCMs
and motor deficits in animals. It is suggested that GTE may
not exert its antioxidative effects in support of EPS inhibition, and remarkably potentiate HAL-induced EPS instead.
Conversely HAL-induced an increase in HVA/dopamine
turnover ratios was persistent in the nucleus accumbens at
GTE combination. That may preserve schizophrenic symptoms or sustain recurrence of schizophrenic symptoms. We
suggest that patients on either HAL therapy, or suffering from
schizophrenia should avoid green tea.
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